ABCG2 and neoplasm: Taken together, the three adverse growth conditions in the tumor microenvironment tested were found to upregulate ABCG2 to mediate multidrug resistance, with the possible enhancing effect on preexisting MDR mechanism, and to give rise to a more malignant phenotype.